Jack Phillips - Apr 4, 2025 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Executive Officer, Director
Signature: /s/ David Patience, attorney-in-fact
Stock symbol: AXDX
Transactions as of: Apr 4, 2025
Transactions value $: -$16,473
Form type: 4
Date filed: 4/7/2025, 07:34 PM
Previous filing: Feb 4, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+53.3K	+32.6%	$0.00	217K	Apr 4, 2025	Direct	F1
transaction	AXDX	Common Stock	Sale	-$16.5K	-25.3K	-11.69%	$0.65	191K	Apr 4, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-53.3K	-100%	$0.00	0	Apr 4, 2025	Common Stock	53.3K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2	The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
F3	On April 4, 2022, the reporting person was granted a total of 88,806 RSUs, of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025.